ex-iskon-pleme
Would you like to react to this message? Create an account in a few clicks or log in to continue.

The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel

Go down

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Empty The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel

Post by Eroo 1/11/2021, 00:14

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel LANCET-1532516601370

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Screenshot-638


Treća injekcija Pfizer cjepiva protiv koronavirusa smanjuje šanse za hospitalizaciju
za 93%, ozbiljne bolesti za 92% i smrtnost za 81%, prema izraelsko-američkoj studiji
objavljenoj u petak navečer u Lancetu.
Studiju, koja je uporedila skoro 730.000 ispitanika koji su primili treće cjepivo sa istim
brojem cijepljenih sa dvije doze pet mjeseci ili više, a nisu primili dopunsko cjepivo,
sproveli su istraživači Zdravstvene službe Clalit i sveučilišta Harvard.
Konkretno, istraživači Clalit i Harvard analizirali su anonimne podatke o 728.321 Clalit
osobu koji su primili treću dozu cjepiva u poređenju sa kontrolnom grupom koja je
uključivala 728.321 osobu koja je primila samo dvije doze.


https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext
Eroo
Eroo

Posts : 79085
2016-07-22


Back to top Go down

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Empty Re: The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel

Post by Eroo 1/11/2021, 01:01

Na ovo istraživanje i zaključke se ne namjeravam više vraćati.
Zaključak je : Treća  doza će  biti neminovna  5 mjeseci nakon druge doze.
Više puta sam "neukom" objasnio zašto je  u Israelu došlo do ponovnog rasta
zaraze i naglasio sam  da su zakasnili s booster dozom mjesec dana,  što se odlično
vidi i iz ove studije. Evo sam si čestitao i nagradio se jednim gin-tonicom. :D
Eroo
Eroo

Posts : 79085
2016-07-22


Back to top Go down

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Empty Re: The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel

Post by T. 1/11/2021, 01:13

https://fort-russ.com/2020/06/exposed-who-admits-it-used-fake-lancet-study-to-stop-hydroxychloroquine-killing-tens-of-thousands/

_________________
 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Bez_na44
T.
T.

Posts : 17594
2014-04-14

Age : 83

Back to top Go down

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Empty Re: The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel

Post by Eroo 1/11/2021, 01:27

T. wrote:https://fort-russ.com/2020/06/exposed-who-admits-it-used-fake-lancet-study-to-stop-hydroxychloroquine-killing-tens-of-thousands/

U Hrvatskoj se do sada zarazilo (potvrđeno) : 470,348 oosoba od toga nije preživjelo 1.96%.
Dakle, ozdravilo ih je 98.04%. Bez hydroxychloroquina... :rasta
Eroo
Eroo

Posts : 79085
2016-07-22


Back to top Go down

 The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel Empty Re: The Lancet Journal: Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel

Post by Sponsored content


Sponsored content


Back to top Go down

Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum